Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1Bärbel Schröfelbauer, Yoshiyuki Hakata, Nathaniel R LandauCurrent HIV/AIDS Reports|January 20, 2009
Accessories to the crime: recent advances in HIV accessory protein biologyThomas Gramberg, Nicole Sunseri, Nathaniel R LandauProceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical modelTakuya Tada, Julia Minnee, Nathaniel R LandauVirology|July 24, 2018
Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperinBénédicte Vanwalscappel, Takuya Tada, Nathaniel R LandauJournal of Virology|November 20, 2009
Evidence for an activation domain at the amino terminus of simian immunodeficiency virus VpxThomas Gramberg, Nicole Sunseri, Nathaniel R LandauAIDS Reviews|June 1, 2004
New insights into the role of Vif in HIV-1 replicationBärbel Schröfelbauer, Qin Yu, Nathaniel R LandauVirology|March 24, 2009
Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependentEdward P Browne, Carolina Allers, Nathaniel R LandauJournal of Virology|April 22, 2011
Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cellsNicole Sunseri, Meagan O'Brien, Nina Bhardwaj, et al.Retrovirology|December 2, 2016
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytesHenning Hofmann, Bénédicte Vanwalscappel, Nicolin Bloch, et al.Journal of Virology|May 30, 2006
Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3GBärbel Schröfelbauer, Tilo Senger, Gerard Manning, et al.Pageof 9